Despite advances in medical therapy to decrease morbidity and mortality in heart failure with reduced ejection fraction, age-adjusted mortality rates in 2021 were higher than in 1999, and rates of hospitalizations have increased since 2014. This highlights the ongoing need for optimizing patient care through improved prescribing of guideline-directed medical therapy (GDMT). The four pillars of